A detailed history of High Tower Advisors, LLC transactions in Bioventus Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 12,237 shares of BVS stock, worth $140,725. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,237
Previous 12,237 -0.0%
Holding current value
$140,725
Previous $70,000 108.57%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$3.96 - $6.93 $48,458 - $84,802
12,237 New
12,237 $70,000
Q2 2022

Aug 10, 2022

BUY
$6.82 - $13.82 $5,831 - $11,816
855 Added 5.71%
15,820 $109,000
Q1 2022

May 12, 2022

BUY
$11.65 - $15.28 $23,381 - $30,666
2,007 Added 15.49%
14,965 $211,000
Q4 2021

Feb 10, 2022

BUY
$12.37 - $16.77 $160,290 - $217,305
12,958 New
12,958 $188,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $709M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.